However, much larger analyses using the genetic approach we and others have described, as well as intervention studies involving a new, specific CRP-inhibitor [53] are needed to more definitively assess the potential causal role for CRP in atherosclerosis and CHD. This evidence concerns the gene CRP and coronary artery disorder.